Effects of Lovastatin on Melanoma and Angiogenesis
Author Information
Author(s): Depasquale Ivan, Wheatley Denys N
Primary Institution: St John's Hospital, Livingston, UK
Hypothesis
Does Lovastatin affect the growth of melanoma cells and their angiogenic activity?
Conclusion
Lovastatin can reduce melanoma cell growth and angiogenic activity in co-cultures.
Supporting Evidence
- Lovastatin inhibited the growth of all cell types in the study.
- Statistically significant increases in tubule formation were observed in co-cultures.
- Lovastatin's effects were reversed by geranylgeranyl pyrophosphate.
Takeaway
Lovastatin is a medicine that can help stop cancer cells from growing and making new blood vessels.
Methodology
The study used co-cultures of melanoma cell lines with human endothelial cells to assess the effects of Lovastatin on angiogenesis.
Potential Biases
Potential bias due to the authors' affiliations and funding sources.
Limitations
The in vitro model may not fully replicate the complex interactions in a living organism.
Participant Demographics
Participants were from a clinical trial with 3304 individuals, but specific demographics were not detailed.
Statistical Information
P-Value
0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website